Frederick M. Abbott

Frederick M. Abbott's AcademicInfluence.com Rankings

Frederick M. Abbott

Law

#523

World Rank

#718

Historical Rank

#312

USA Rank

International Law

#164

World Rank

#229

Historical Rank

#64

USA Rank

law Degrees

Download Badge

Why Is Frederick M. Abbott Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Frederick M. Abbott is an American legal academic who is active in scholarly and public policy discussion involving global intellectual property protections and economic law, especially access to medicine. He holds the Edward Ball Eminent Scholar at Florida State University College of Law. He has written scores of journal articles and his books include The International Intellectual Property System: Commentary and Materials , China in the World Trading System: Defining the Principles of Engagement , Public Policy and Global Technological Integration , and Law and Policy of Regional Integration . His book on treaty-making, Parliamentary Participation in the Making and Operation of Treaties, edited with Stefan Riesenfeld, was awarded the American Society of International Law Certificate of Merit.

(See a Problem?)

Frederick M. Abbott's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Doha Declaration on the TRIPS Agreement and Public Health: Lighting a Dark Corner at the WTO (2002) (159)
The WTO Medicines Decision: World Pharmaceutical Trade and the Protection of Public Health (2005) (154)
The Doha Round's Public Health Legacy: Strategies for the Production and Diffusion of Patented Medicines Under the Amended TRIPS Provisions (2007) (147)
NAFTA and the Legalization of World Politics: A Case Study (2000) (130)
First Report (Final) to the Committee on International Trade Law of the International Law Association on the Subject of Parallel Importation (1998) (77)
The Doha Declaration on the TRIPS Agreement and Public Health and the Contradictory Trend in Bilateral and Regional Free Trade Agreements (2011) (61)
The Trips Agreement, Access to Medicines and the WTO Doha Ministerial Conference (2005) (51)
Protecting First World Assets in the Third World: Intellectual Property Negotiations in the GATT Multilateral Framework (1989) (47)
Distributed governance at the WTO-WIPO: an evolving model for open-architecture integrated governance (2000) (43)
Toward a New Era of Objective Assessment in the Field of TRIPS and Variable Geometry for the Preservation of Multilateralism (2005) (41)
Intellectual Property Provisions of Bilateral and Regional Trade Agreements in Light of U.S. Federal Law (2011) (40)
Innovation and Technology Transfer to Address Climate Change: Lessons from the Global Debate on Intellectual Property and Public Health (2009) (39)
The Enduring Enigma of TRIPS: A Challenge for the World Economic System (1998) (38)
A New Dominant Trade Species Emerges: Is Bilateralism a Threat? (2007) (32)
International Intellectual Property in an Integrated World Economy (2007) (31)
WTO TRIPS Agreement and its Implications for Access to Medicines in Developing Countries (2002) (31)
The International Intellectual Property System: Commentary and Materials (1999) (29)
An International Legal Framework for the Sharing of Pathogens: Issues and Challenges (2010) (28)
Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow's World (2009) (22)
Emerging Markets and the World Patent Order (2014) (21)
International Trade and Human Rights. Foundations and Conceptual Issues (2006) (21)
The WTO TRIPS Agreement and Global Economic Development (1996) (18)
Excessive Pharmaceutical Prices and Competition Law: Doctrinal Development to Protect Public Health (2016) (18)
World Trade Organization Accession Agreements: Intellectual Property Issues (2007) (18)
TRIPS in Seattle: The Not-so-Surprising Failure and the Future of the TRIPS Agenda (2000) (17)
Indian Policies to Promote Local Production of Pharmaceutical Products and Protect Public Health (2017) (17)
Seizure of Generic Pharmaceuticals in Transit Based on Allegations of Patent Infringement: A Threat to International Trade, Development and Public Welfare (2009) (16)
The TRIPS-Legality of Measures Taken to Address Public Health Crises: Responding to USTR-State-Industry Positions That Undermine the WTO (2001) (15)
Global Pharmaceutical Policy (2009) (14)
Cross-Retaliation in TRIPS: Options for Developing Countries (2009) (14)
Integration Without Institutions: The NAFTA Mutation of the EC Model and the Future of the GATT Regime (1992) (14)
Parliamentary participation in the making and operation of treaties : a comparative study (1994) (14)
Facilitating Access to Cross-Border Supplies of Patented Pharmaceuticals: The Case of the COVID-19 Pandemic (2020) (13)
Parallel Importation: Economic and Social Welfare Dimensions (2007) (13)
The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 Pandemic (2020) (13)
The Scope of U.S. Senate Control Over the Conclusion and Operation of Treaties (1992) (12)
Trends in Local Production of Medicines and Related Technology Transfer (2011) (12)
Foreword: Symposium on Parliamentary Participation in the Making and Operation of Treaties (1991) (11)
The Future of IPRs in the Multilateral Trading System (2003) (10)
The Intersection of Law and Trade in the WTO System: Economics and the Transition to a Hard Law System (1995) (10)
Law and Policy of Regional Integration: the NAFTA and Western Hemispheric Integration in the World Trade Organization System (1995) (10)
The Future of the Multilateral Trading System in the Context of TRIPS (1997) (10)
Managing the Hydra: The Herculean Task of Ensuring Access to Essential Medicines (2004) (10)
The ‘Rule of Reason’ and the Right to Health: Integrating Human Rights and Competition Principles in the Context of TRIPS (2003) (9)
Bargaining Power and Strategy in the Foreign Investment Process: A Current Andean Code Analysis (1975) (9)
The North American Integration Regime and its Implications for the World Trading System (2000) (9)
UNDP, Using Competition Law to Promote Access to Health Technologies: A Guidebook for Low- and Middle-Income Countries (2014) (8)
A pandemic treaty for equitable global access to medical countermeasures: seven recommendations for sharing intellectual property, know-how and technology (2022) (8)
Regional Integration Mechanisms in the Law of the United States: Starting Over (1993) (7)
Reflection Paper on China in the World Trading System: Defining the Principles of Engagement (1997) (7)
Compulsory Licensing for Public Health Needs: The TRIPS Agenda at the WTO after the Doha Declaration on Public Health (2011) (7)
International Trade and Human Rights (2005) (7)
WTO Dispute Settlement Practice Relating to the Agreement on Trade-Related Intellectual Property Rights (2003) (6)
Multilevel governance of interdependent public goods : theories, rules and institutions for the central policy challenge in the 21st Century (2012) (6)
Are the Competition Rules in the WTO TRIPS Agreement Adequate? (2004) (6)
TRIPS and Human Rights: Preliminary Reflections (2006) (6)
Intellectual Property Rights in World Trade (2007) (6)
Medicines for the Developing World (2009) (5)
Trips II, Asia and the Mercantile Pharmaceutical War: Implications for Innovation and Access (2006) (5)
ICTSD Programme on IPRs and Sustainable Development Views on the Future of the Intellectual Property System (2007) (5)
ICTSD Programme on IPRs and Sustainable Development Views on the Future of the Intellectual Property System (2007) (5)
International Trade and Human Rights: Foundations and Conceptual Issues (World Trade Forum, Volume 5) (2006) (5)
Trade Costs and Shadow Benefits: EU Economic Partnership Agreements as Models for Progressive Development of International IP Law (2013) (5)
The Judgment in Novartis v. India: What the Supreme Court of India Said (2013) (5)
Comparative Study of Selected Government Policies for Promoting Transfer of Technology and Competitiveness in the Colombian Pharmaceutical Sector (2007) (4)
Foundation Building for Western Hemispheric Integration (1996) (4)
Regional Assessment of Patent and Related Issues and Access to Medicines: Caricom Member States and the Dominican Republic (HERA) (2009) (4)
Trade and Democratic Values (1991) (4)
Current Alliances in International Intellectual Property Lawmaking: The Emergence and Impact of Mega-Regionals (2017) (4)
Technical Note: The LDC TRIPS Transition Extension and the Question of Rollback (2013) (4)
Technology and State Enterprise in the WTO (1997) (3)
Non-Violation Nullification or Impairment Causes of Action Under the TRIPS Agreement and the Fifth Ministerial Conference: A Warning and Reminder (2003) (3)
Public Policy and Global Technological Integration: An Introduction (1996) (3)
Seizure of generic pharmaceuticals in transit based on allegations of patent infringement: A threat to international trade, development and public welfare: Intellectual Property and Access to Essential Medicines (2013) (3)
Submission to the UN High Level Panel on Access to Medicines by the Global Health Law Committee of the International Law Association : Proposal for an essential Medicines Patent Pool (2016) (3)
Intellectual Property and Public Health: Meeting the Challenge of Sustainability (2011) (3)
The Law, Economics and Politics of Retaliation in WTO Dispute Settlement: Cross-retaliation in TRIPS: issues of law and practice (2010) (3)
The problems of intellectual property in Latin America and how to address them (2007) (3)
From Theory to Practice:The Second Phase of the NAFTA Environmental Regime (1996) (3)
Are the Competition Rules in the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights Adequate? (2005) (3)
Patents, Biotechnology and Human Rights: The Preservation of Biodiverse Resources for Future Generations (2006) (3)
Reflections on the Report of the UN Secretary General's High Level Panel on Access to Medicines. (2017) (3)
Trade Diplomacy, the Rule of Law and the Problem of Asymmetric Risks in TRIPS (2003) (2)
The NAFTA Environmental Dispute Settlement System as Prototype for Regional Integration Arrangements (2012) (2)
Opportunities, Constraints and Critical Supports for Achieving Sustainable Local Pharmaceutical Manufacturing in Africa: With a Focus on the Role of Finance, Final Report (2021) (2)
Regional Integration and the Environment: The Evolution of Legal Regimes (1992) (2)
The Silhouette of a Trojan Horse: Reflections on Advocate General Jacobs' Opinion in Silhouette v. Hartlauer (1998) (2)
On the Duality of Internet Domain Names: Propertization and Its Discontents (2013) (2)
GATT and the European Community: A Formula for Peaceful Coexistence (2011) (2)
World Intellectual Property Organization: Treaty on Intellectual Property in Respect of Integrated Circuits (1989) (2)
Opportunities and Challenges for Sustainable Development in China and Beyond (2009) (2)
Trade in Medicines (2015) (2)
Intellectual Property Rights and Climate Change: Interpreting the TRIPS Agreement for Environmentally Sound Technologies. By WEI ZHUANG (2018) (2)
The Evolution of Public Health Provisions in Preferential Trade and Investment Agreements of the United States (2017) (2)
Intellectual Property, International Protection (2009) (2)
Review: The Trilateral Study on Health, Intellectual Property, and Trade: The Virtue in Paving a Cleared Roadway (2013) (2)
Opportunities, Constraints and Critical Supports for Achieving Sustainable Local Pharmaceutical Manufacturing in Africa: With a Focus on the Role of Finance (2021) (2)
The Political Economy of NAFTA Chapter Eleven: Equality Before the Law and the Boundaries of North American Integration (2000) (1)
The UK Competition Appeal Tribunal’s Misguided Reprieve for Pfizer’s Excessive Pricing Abuse (2018) (1)
Chapter 02 - Public–Private Partnerships as Models for New Drug Research and Development: The Future as Now (2018) (1)
Transfer of Technology and a Global Clean Energy Grid (2015) (1)
Child-Proofing Global Public Health in Anticipation of Emergency (2021) (1)
Public-Private Partnerships As Models for New Drug Development: The Future As Now (2016) (1)
China in the WTO 2006: 'Law and its Limitations' in the Context of TRIPS (2011) (1)
Comment on the US Supreme Court Decision “Impression Products v. Lexmark International” (2017) (1)
Promoting Innovation: Patents, Subsidies, Prizes and Prices (2009) (1)
NAFTA and the Future of United States — European Community Trade Relations: The Consequences of Asymmetry in an Emerging Era of Regionalism (1993) (1)
World Trade Organization Canada First Notice to Manufacture Generic Drug for Export (2007) (0)
Political Economy of the U.S. Parallel Trade Experience: Toward a More Thoughtful Policy (2000) (0)
Legislative and Regulatory Takings of Intellectual Property: Early Stage Intervention Against a New Jurisprudential Virus (2019) (0)
IV.33 Right to Access to Medicines (2017) (0)
TRIPS, Strategic Competition and Global Welfare: IP at the Intersection of Law and Power (2019) (0)
Technology Governance in a Devolved Global Legal Order (2019) (0)
The Generics Pathway in the USA: The American Experience, a Model for the World? (2015) (0)
The Challenges We Face (2009) (0)
III.15 The Impact of Preferential Trade Agreements (2017) (0)
AJI volume 102 issue 3 Cover and Back matter (2008) (0)
GATT Law on Agricultural Trade in Light of the United Nations Conference on Environment and Development (2012) (0)
The UK Competition Appeal Tribunal’s Misguided Reprieve for Pfizer’s Excessive Pricing Abuse (2018) (0)
World Trade Organization: Canada First Notice to Manufacture Generic Drug for Export : Introductory Note (2007) (0)
The LDC Medicines Extension Question: Contemplating Next Steps (2014) (0)
The Use of Medicines: Education, Information and Persuasion (2009) (0)
Crosscurrents in European Union External Commercial Relations: The Controversy Over the Germany-United States Treaty of Friendship (2011) (0)
Rethinking Patents: From ‘Intellectual Property’ to ‘Private Taxation Scheme’ (2015) (0)
Emerging Market Pharmaceutical Supply: A Prescription for Sharing the Benefits of Global Information Flow (2010) (0)
Let International Competition Negotiations Sleep a While Longer: Focus on Tools and Capacity (2018) (0)
Health and intellectual property rights (2018) (0)
The ACTA and the Plurilateral Enforcement Agenda: An Overview of the Agreement (2014) (0)
Respect for Copyright Sovereignty in Transit: The European Court of Justice Decision in the Joined Philips/Nokia Cases (2013) (0)
Prosecuting Excessive Pricing of Pharmaceuticals under Competition Law: Evolutionary Development (2023) (0)
AJI volume 99 issue 2 Cover and Front matter (2005) (0)
Competition Law in Emerging Markets (2016) (0)
The United States Response to Emerging Technological Powers (2013) (0)
The North American Free Trade Agreement (NAFTA): Structure, Dispute Settlement and Case Law (2014) (0)
Science, Scarcity and Public Health: The Search for New Pharma Models (2013) (0)
Dispute Prevention and Dispute Settlement in the Field of Intellectual Property Rights and Electronic Commerce, United States-Section 211 Omnibus Appropriations Act 1998 ('Havana Club') (2002) (0)
III.74 Goals, Principles and Minimum Standards of Protection of Intellectual Property Rights (2017) (0)
Remarks by Frederick Abbott (2000) (0)
World Trade Organization - TRIPS - Course on Dispute Settlement in International Trade, Investment and Intellectual Property (UNCTAD) (2003) (0)
Inside Views : Excessive Pricing And Sham Patent Litigation : The P zer And AbbVie Decisions (2018) (0)
Policies on Innovation: Past, Present and Future (2009) (0)
Inside Views : Excessive Pricing And Sham Patent Litigation : The P zer And AbbVie Decisions (2018) (0)
Introductory Remarks by Frederick M. Abbott (2014) (0)
Remarks by Frederick M. Abbott (2002) (0)
Edinburgh Review - Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World (2017) (0)
Regulation and the Role of the Courts (2009) (0)
ILM volume 47 issue 6 cover and Front matter (2008) (0)
Global and Regional Policies: The Way Ahead (2009) (0)
Specialized Policy Areas: Vaccines, Biologicals and Blood Products; Alternative and Traditional Medicines; Self-Medication; Counterfeit Medicines (2009) (0)
Local Production of Pharmaceutical Products in Africa: The WHO approach (2014) (0)
Prof. Ernst-Ulrich Petersmann and the Work of the ILA Committee on International Trade Law (1993–2012) (2014) (0)
Remarks by Frederick M. Abbott (2004) (0)
Emerging Market Pharmaceutical Supply (2011) (0)
Intellectual Property Rights: A Concise Guide (Chapter 2), and Intellectual Property Rights: How They Affect Procurement and What Steps Can Be Taken (Annex B) (2004) (0)
WTO Dispute Settlement and the Agreement on Trade-Related Aspects of Intellectual Property Rights (2012) (0)
Let International Competition Negotiations Sleep a While Longer: Focus on Tools and Capacity (2018) (0)
BOOK REVIEW GLOBAL PHARMACEUTICAL POLICY: ENSURING MEDICINES FOR TOMORROW’S WORLD (2011) (0)
Chapter: Health and Intellectual Property (2017) (0)
Parallel Trade in Pharmaceuticals: Trade Therapy for Market Distortions (2016) (0)
Industrial Policy, Innovation and Economic Stress: Opportunities and Risks (2009) (0)
The Global Regulatory Environment: Quality, Safety and Efficacy (2009) (0)
Under the Radar: Reflections on ‘Forced’ Technology Transfer and the Erosion of Developmental Sovereignty (2019) (0)
Preservation and Use of Genetic Resource Assets and the International Patent System (2005) (0)
Anti-Competitive Behaviours and the Remedies Available for Redress (2014) (0)
The Maastricht Judgment, the Democracy Principle, and US Participation in Western Hemispheric Integration (1994) (0)
Report of the 78th Conference International Law Association. Report of the Global health law Committee: International Law Association. Report of the Global health law Committee (2018) (0)
The Rich, the Poor and the Neglected (2009) (0)
Comment on the US Supreme Court Decision “Impression Products v. Lexmark International” (2017) (0)

This paper list is powered by the following services:

Other Resources About Frederick M. Abbott

en.wikipedia.org

What Schools Are Affiliated With Frederick M. Abbott?

Frederick M. Abbott is affiliated with the following schools:

Florida State University